PMID- 32973804 OWN - NLM STAT- MEDLINE DCOM- 20210430 LR - 20210430 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 11 DP - 2020 TI - Human Regulatory Dendritic Cells Develop From Monocytes in Response to Signals From Regulatory and Helper T Cells. PG - 1982 LID - 10.3389/fimmu.2020.01982 [doi] LID - 1982 AB - Dendritic cells (DCs) are powerful antigen presenting cells, derived from bone marrow progenitors (cDCs) and monocytes (moDCs), that can shape the immune response by priming either proinflammatory or tolerogenic immune effector cells. The cellular mechanisms responsible for the generation of DCs that will prime a proinflammatory or tolerogenic response are poorly understood. Here we describe a novel mechanism by which tolerogenic DCs are formed from monocytes. When human monocytes were cultured with CD4(+)FoxP3(+) natural regulatory T cells (Tregs) and T helper cells (Th) from healthy donor blood, they differentiated into regulatory DCs (DC (Reg) ), capable of generating induced Tregs from naive T cells. DC (Reg) exhibited morphology, surface phenotype, cytokine secretion, and transcriptome that were distinct from other moDCs including those derived from monocytes cultured with Th or with GM-CSF/IL-4, as well as macrophages (MPhi). Direct cell contact between monocytes, Tregs and Th, along with Treg-derived CTLA-4, IL-10 and TGF-beta, was required for the phenotypic differentiation of DC (Reg) , although only IL-10 was required for imprinting the Treg-inducing capacity of DC (Reg) . High ratios of Treg:Th, along with monocytes and DC (Reg) similar in function and phenotype to those induced in vitro, were present in situ in human colorectal cancer specimens. Thus, through the combined actions of Tregs and Th, monocytes differentiate into DCs with regulatory properties, forming a positive feedback loop to reinforce Treg initiated immune regulation. This mechanism may contribute to immune tolerance in tissues such as tumors, which contain an abundance of Tregs, Th and monocytes. CI - Copyright (c) 2020 Zhang, Zheng, Prestwood, Zhang, Carmi, Tolentino, Wu, Choi, Winer, Strober, Kang, Alonso and Engleman. FAU - Zhang, Xiangyue AU - Zhang X AD - Department of Pathology, Blood Center, Stanford University School of Medicine, Palo Alto, CA, United States. FAU - Zheng, Pingping AU - Zheng P AD - Bone Marrow Transplantation, Stanford University School of Medicine, Palo Alto, CA, United States. FAU - Prestwood, Tyler R AU - Prestwood TR AD - Department of Pathology, Blood Center, Stanford University School of Medicine, Palo Alto, CA, United States. FAU - Zhang, Hong AU - Zhang H AD - Department of Pathology, Blood Center, Stanford University School of Medicine, Palo Alto, CA, United States. FAU - Carmi, Yaron AU - Carmi Y AD - Department of Pathology, Blood Center, Stanford University School of Medicine, Palo Alto, CA, United States. FAU - Tolentino, Lorna L AU - Tolentino LL AD - Department of Pathology, Blood Center, Stanford University School of Medicine, Palo Alto, CA, United States. FAU - Wu, Nancy AU - Wu N AD - Department of Pathology, Blood Center, Stanford University School of Medicine, Palo Alto, CA, United States. FAU - Choi, Okmi AU - Choi O AD - Department of Pathology, Blood Center, Stanford University School of Medicine, Palo Alto, CA, United States. FAU - Winer, Daniel A AU - Winer DA AD - Buck Institute for Research on Aging, Novato, CA, United States. AD - Division of Cellular and Molecular Biology, Diabetes Research Group, Toronto General Hospital Research Institute (TGHRI), University Health Network, Toronto, ON, Canada. FAU - Strober, Samuel AU - Strober S AD - Division of Immunology and Rheumatology, Department of Medicine, Stanford University of Medicine, Stanford, CA, United States. FAU - Kang, Eun-Suk AU - Kang ES AD - Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea. FAU - Alonso, Michael N AU - Alonso MN AD - Department of Pathology, Blood Center, Stanford University School of Medicine, Palo Alto, CA, United States. FAU - Engleman, Edgar G AU - Engleman EG AD - Department of Pathology, Blood Center, Stanford University School of Medicine, Palo Alto, CA, United States. LA - eng GR - P01 HL075462/HL/NHLBI NIH HHS/United States GR - R01 AI118884/AI/NIAID NIH HHS/United States GR - R01 CA222969/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20200818 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 0 (Biomarkers) SB - IM MH - Biomarkers MH - CD4-Positive T-Lymphocytes/immunology/metabolism MH - *Cell Communication/immunology MH - Cell Differentiation MH - Colonic Neoplasms/immunology/metabolism/pathology MH - Computational Biology/methods MH - Dendritic Cells/*immunology/*metabolism MH - Gene Expression Profiling MH - Humans MH - Immunomodulation MH - Immunophenotyping MH - Monocytes/*immunology/metabolism MH - *Signal Transduction MH - T-Lymphocyte Subsets/immunology/metabolism MH - T-Lymphocytes, Regulatory/*immunology/*metabolism MH - Transcriptome PMC - PMC7461788 OTO - NOTNLM OT - DCReg OT - DCs OT - Th OT - Tregs OT - monocytes EDAT- 2020/09/26 06:00 MHDA- 2021/05/01 06:00 PMCR- 2020/01/01 CRDT- 2020/09/25 06:02 PHST- 2020/04/08 00:00 [received] PHST- 2020/07/22 00:00 [accepted] PHST- 2020/09/25 06:02 [entrez] PHST- 2020/09/26 06:00 [pubmed] PHST- 2021/05/01 06:00 [medline] PHST- 2020/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2020.01982 [doi] PST - epublish SO - Front Immunol. 2020 Aug 18;11:1982. doi: 10.3389/fimmu.2020.01982. eCollection 2020.